At the conference’s milestone 20th anniversary event in Boston, experts unpacked the final stages of DSCSA implementation, highlighting pharmacy compliance challenges, state-level variability, and the ...
Drug shortages impact patient care, hospital operations, and pharmacy systems, necessitating strategic mitigation efforts to enhance supply chain resilience. Cross-industry collaborations, such as the ...
This episode of Pharma Pulse covers new data showing measles vaccine coverage remains below herd immunity thresholds, the FDA’s approval of guselkumab for pediatric plaque psoriasis and psoriatic ...
This episode of Pharma Pulse covers the Trump administration’s 100% tariff on branded drug imports, new research linking pediatric influenza to neurological complications amid vaccination gaps, and ...
This episode of Pharma Pulse covers new research showing Medicaid cuts could widen pediatric coverage gaps, clinical trial ...
Through its “BMS Patient Connect” platform, the company is lowering out-of-pocket costs and providing nationwide shipping, making the treatment for affordable and accessible for US patients.
This episode of Pharma Pulse covers the CDC’s unanimous vote to broaden COVID-19 vaccine recommendations for all adults, new ...
Closed Loop Medicine Debuts WeDosify in US to Personalize GLP-1 Dosing and Improve Patient Adherence
The platform enables clinicians to tailor GLP-1 titration at scale, aiming to reduce discontinuation rates and improve ...
Omnichannel orchestration: Enables tailored messages across platforms in real time to meet the patient or HCP where they are with what they need. Whether it’s through email, social media, HCP portals, ...
Beginning Oct. 1, the US will impose a 100% tariff on branded and patented pharmaceutical imports unless manufacturers are actively building domestic production facilities, a move aimed at reshoring ...
The Generation Park site will create over 600 permanent jobs, support advanced small molecule production, and play a role in ...
This episode of Pharma Pulse covers ACIP’s move toward shared decision-making for COVID-19 vaccines, Pfizer’s acquisition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback